First, an important characteristic of our study design was to utilize ICU patients without AKI as the comparison group, rather than healthy volunteers without comorbidities (e.g., IL-17A levels from young adult healthy volunteers are ~ 50% lower compared with non-AKI ICU patients in our study, data not shown). The gene discussed is IL17A; the disease is acute kidney injury.